INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994 | +235.8% | 31,436 | +333.1% | 0.01% | +350.0% |
| Q2 2023 | $296 | -14.9% | 7,258 | -27.3% | 0.00% | -60.0% |
| Q4 2022 | $348 | -100.0% | 9,982 | -41.9% | 0.01% | -61.5% |
| Q3 2022 | $962,000 | +135.2% | 17,186 | +117.5% | 0.01% | +160.0% |
| Q2 2022 | $409,000 | -67.4% | 7,903 | -54.2% | 0.01% | -68.8% |
| Q1 2022 | $1,253,000 | +169.5% | 17,243 | +397.3% | 0.02% | +166.7% |
| Q3 2021 | $465,000 | -6.4% | 3,467 | -62.0% | 0.01% | +20.0% |
| Q4 2020 | $497,000 | -54.3% | 9,134 | -83.3% | 0.01% | -77.3% |
| Q3 2020 | $1,088,000 | +33.2% | 54,723 | +40.7% | 0.02% | +4.8% |
| Q2 2020 | $817,000 | +366.9% | 38,882 | +197.1% | 0.02% | +250.0% |
| Q3 2019 | $175,000 | – | 13,089 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |